Terms: = Brain cancer AND MTOR, FRAP2, FRAP1, 2475, ENSG00000198793, P42345, RAPT1, RAFT1, FRAP, FLJ44809 AND Diagnosis
85 results:
1. Multi-omics technologies and molecular biomarkers in brain tumor-related epilepsy.
Du Y; Li R; Fu D; Zhang B; Cui A; Shao Y; Lai Z; Chen R; Chen B; Wang Z; Zhang W; Chu L
CNS Neurosci Ther; 2024 Apr; 30(4):e14717. PubMed ID: 38641945
[TBL] [Abstract] [Full Text] [Related]
2. Advances in genetic abnormalities, epigenetic reprogramming, and immune landscape of intracranial germ cell tumors.
Zhang Y; Zhong C; Ke X; Liu J; Ye Z; Lu L; Deng K; Zhu H; Yao Y
Acta Neuropathol Commun; 2023 Nov; 11(1):188. PubMed ID: 38012690
[TBL] [Abstract] [Full Text] [Related]
3. Glutamine synthetase and hepatocellular carcinoma.
Jiang J; Hu Y; Fang D; Luo J
Clin Res Hepatol Gastroenterol; 2023 Dec; 47(10):102248. PubMed ID: 37979911
[TBL] [Abstract] [Full Text] [Related]
4. The Glioblastoma CircularRNAome.
Tirpe A; Streianu C; Tirpe SM; Kocijancic A; Pirlog R; Pirlog B; Busuioc C; Pop OL; Berindan-Neagoe I
Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37833993
[TBL] [Abstract] [Full Text] [Related]
5. Case Report: brainstem angiocentric glioma presenting in a toddler child-diagnostic and therapeutic challenges.
Reisz Z; Radics BL; Nemes P; Laxton R; Kaizer L; Gabor KM; Novak T; Barzo P; Al-Sarraj S; Bodi I
Pathol Oncol Res; 2023; 29():1611231. PubMed ID: 37362245
[No Abstract] [Full Text] [Related]
6. Clinicogenomic factors and treatment patterns among patients with advanced non-small cell lung cancer with or without brain metastases in the United States.
Smyth EN; John J; Tiu RV; Willard MD; Beyrer JK; Bowman L; Sheffield KM; Han Y; Brastianos PK
Oncologist; 2023 Nov; 28(11):e1075-e1091. PubMed ID: 37358877
[TBL] [Abstract] [Full Text] [Related]
7. Kaposiform hemangioendothelioma of skull base with dura invasion in a pediatric patient: a case report.
Jung SC; Jung TY; Lee TK; Kim YJ; Baek HJ; Kim SS
Childs Nerv Syst; 2023 Nov; 39(11):3289-3294. PubMed ID: 37354290
[TBL] [Abstract] [Full Text] [Related]
8. The role of environmental factors on sporadic Creutzfeldt-Jakob disease mortality: evidence from an age-period-cohort analysis.
Denouel A; Brandel JP; Seilhean D; Laplanche JL; Elbaz A; Haik S
Eur J Epidemiol; 2023 Jul; 38(7):757-764. PubMed ID: 37191829
[TBL] [Abstract] [Full Text] [Related]
9. Predictive significance of PRR11 in prognosis and immune infiltration of glioma patients.
Han W; Chen L
Mol Carcinog; 2023 Jul; 62(7):975-990. PubMed ID: 37036189
[TBL] [Abstract] [Full Text] [Related]
10. Approach to the Patient With Prolactinoma.
Auriemma RS; Pirchio R; Pivonello C; Garifalos F; Colao A; Pivonello R
J Clin Endocrinol Metab; 2023 Aug; 108(9):2400-2423. PubMed ID: 36974474
[TBL] [Abstract] [Full Text] [Related]
11. Polymorphisms in
Morais de Castro E; Barbosa LV; Simoneti Fonseca A; Nagashima S; Busatta Vaz de Paula C; Zeni R; Panini do Carmo LA; Cavalli LR; Bleggi Torres LF; Senff Ribeiro A; de Noronha L; Machado-Souza C
ASN Neuro; 2023; 15():17590914231153481. PubMed ID: 36714975
[TBL] [Abstract] [Full Text] [Related]
12. Real-time drug testing of paediatric diffuse midline glioma to support clinical decision making: The Zurich DIPG/DMG centre experience.
Mueller T; Laternser S; Guerreiro Stücklin AS; Gerber NU; Mourabit S; Rizo M; Rushing EJ; Kottke R; Grotzer M; Krayenbühl N; Nazarian J; Mueller S
Eur J Cancer; 2023 Jan; 178():171-179. PubMed ID: 36455411
[TBL] [Abstract] [Full Text] [Related]
13. The clinical and molecular characteristics of progressive hypothalamic/optic pathway pilocytic astrocytoma.
Li X; Moreira DC; Bag AK; Qaddoumi I; Acharya S; Chiang J
Neuro Oncol; 2023 Apr; 25(4):750-760. PubMed ID: 36260562
[TBL] [Abstract] [Full Text] [Related]
14. An update on the molecular biology of glioblastoma, with clinical implications and progress in its treatment.
Verdugo E; Puerto I; Medina MÁ
Cancer Commun (Lond); 2022 Nov; 42(11):1083-1111. PubMed ID: 36129048
[TBL] [Abstract] [Full Text] [Related]
15. Current and promising treatment strategies in glioma.
Śledzińska P; Bebyn M; Furtak J; Koper A; Koper K
Rev Neurosci; 2023 Jul; 34(5):483-516. PubMed ID: 36062548
[TBL] [Abstract] [Full Text] [Related]
16. ASSESSMENT OF THE STATE OF IMMUNE SYSTEM IN PATIENTS WITH METASTATIC AND GLIAL brain TUMORS AT THE PREPARATORY STAGE OF RADIOTHERAPY.
Gryazov AA; Lysianyi MI; Gryazov AB; Medvedovska YV
Wiad Lek; 2022; 75(7):1747-1751. PubMed ID: 35962692
[TBL] [Abstract] [Full Text] [Related]
17. EANO - EURACAN - SNO Guidelines on circumscribed astrocytic gliomas, glioneuronal, and neuronal tumors.
Rudà R; Capper D; Waldman AD; Pallud J; Minniti G; Kaley TJ; Bouffet E; Tabatabai G; Aronica E; Jakola AS; Pfister SM; Schiff D; Lassman AB; Solomon DA; Soffietti R; Weller M; Preusser M; Idbaih A; Wen PY; van den Bent MJ
Neuro Oncol; 2022 Dec; 24(12):2015-2034. PubMed ID: 35908833
[TBL] [Abstract] [Full Text] [Related]
18. Role of Circular RNA in brain Tumor Development.
Ahmed SP; Castresana JS; Shahi MH
Cells; 2022 Jul; 11(14):. PubMed ID: 35883576
[TBL] [Abstract] [Full Text] [Related]
19. Circadian Clock Genes Act as Diagnostic and Prognostic Biomarkers of Glioma: Clinic Implications for Chronotherapy.
Chai R; Liao M; Ou L; Tang Q; Liang Y; Li N; Huang W; Wang X; Zheng K; Wang S
Biomed Res Int; 2022; 2022():9774879. PubMed ID: 35832846
[TBL] [Abstract] [Full Text] [Related]
20. Gliomas: Genetic alterations, mechanisms of metastasis, recurrence, drug resistance, and recent trends in molecular therapeutic options.
Kannan S; Murugan AK; Balasubramanian S; Munirajan AK; Alzahrani AS
Biochem Pharmacol; 2022 Jul; 201():115090. PubMed ID: 35577014
[TBL] [Abstract] [Full Text] [Related]
[Next]
